NATURE’S SUNSHINE PRODUCTS, INC. Available-for-sale Securities, Amortized Cost Basis
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Available-for-sale Securities, Amortized Cost Basis of $1.80 million as of 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-03-16
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $1.80M.
- 2016-12-31: Available-for-sale Securities, Amortized Cost Basis $1.80M.
- 2016-09-30: Available-for-sale Securities, Amortized Cost Basis $1.79M.
- 2016-06-30: Available-for-sale Securities, Amortized Cost Basis $1.79M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2017-03-31 | $1.80M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.80M 10-K · filed 2018-03-16 |
| 2016-09-30 | $1.79M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.79M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.79M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.79M 10-K · filed 2017-03-14 |
| 2015-09-30 | $1.79M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $1.79M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $2.12M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.12M 10-K · filed 2016-03-14 |
| 2014-09-30 | $1.43M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.63M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.63M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.63M 10-K · filed 2015-03-13 |
| 2013-09-30 | $1.73M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.73M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.83M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.83M 10-K · filed 2014-03-17 |
| 2012-09-30 | $1.93M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $2.04M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $5.48M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |